.
  • .
    .

    scottish widows' figures were compiled using the abi guidance for calculating claims statistics..

    harvard medical school: "cgrp: a new era for migraine treatment.".

  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..